“第三届基因治疗产业发展论坛暨基因治疗产业协作组成立大会”拟于2017年10月25日在北京亦庄生物医药园举行。本次论坛由中国医药生物技术协会基因治疗分会主办。北京亦创生物技术产业研究院和中关村美中生物技术产业集群创新联盟联合承办,北京五加和分子医学研究所有限公司、《药学进展》编委会、中国孤儿药创新联盟等单位协办。随着单基因遗传病基因治疗的频频突破,ex vivo转基因细胞治疗(如CAR-T)在美国上市,基因治疗重返中 “The Third Gene Therapy Industry Development Forum and Gene Therapy Industry Collaboration Group Establishment Meeting” to be held on October 25, 2017 in Beijing Yizhuang Bio-Medical Park. This forum is sponsored by the Gene Therapy Branch of China Association of Biotechnology. Beijing Yi Chong Biotechnology Industry Research Institute and the Zhongguancun US-China Biotechnology Industry Cluster Innovation Alliance jointly hosted the Beijing Wuga and Molecular Medicine Institute Co., Ltd., “Pharmaceutical Progress” Editorial Board, China Orphan Drug Innovation Alliance and other units. With the frequent breakthrough of gene therapy of single-gene genetic disease, ex vivo transgenic cell therapy (such as CAR-T) is listed in the United States and gene therapy is returning